The Europe Drug Testing Market is expected to witness market growth of 4.3% CAGR during the forecast period (2021-2027).
Increasing supportive regulations and mandates are expected to boost the growth of the European drug testing market in the upcoming years. For example, workplace drug testing is legal in the UK; however, under some conditions. Employers require employee consent to test for drugs either before or during employment. Along with this, workplace drug testing is legal in France also; however only during employment: tests cannot be performed prior to a contract is signed. Once joined a company, employees can take the test as per the internal norms and regulations of the employer, provided the impact of drugs is expected to become a threat. These supportive policies of drug testing in various countries of this region is expected to fuel the demand & growth of the regional drug testing market during the forecast period.
The right to privacy and prohibition of drug and alcohol testing in various countries are expected to be a leading factor that is slowing down the growth & demand of drug testing in the next few years. In various European nations, like Finland and Belgium, there are strict privacy rights that cannot be neglected while testing for substance abuse. In the Netherlands, pre-employment substance abuse testing is illegal. Several European nations issue penalties for improper testing, with criminal fines. This was a breach of the worker’s privacy. Therefore, these strict privacy rights are expected to hinder the testing process at workplaces, thereby limiting the growth of the market.
The Germany market dominated the Europe Drug Testing Oral Fluid Samples Market by Country 2020, thereby, achieving a market value of $202.4 million by 2027. The UK market is showcasing a CAGR of 3.3% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 4.8% during (2021 - 2027).
Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.
Scope of the Study
Market Segments covered in the Report:
By Drug Type
By Sample Type
By Product Type
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
Increasing supportive regulations and mandates are expected to boost the growth of the European drug testing market in the upcoming years. For example, workplace drug testing is legal in the UK; however, under some conditions. Employers require employee consent to test for drugs either before or during employment. Along with this, workplace drug testing is legal in France also; however only during employment: tests cannot be performed prior to a contract is signed. Once joined a company, employees can take the test as per the internal norms and regulations of the employer, provided the impact of drugs is expected to become a threat. These supportive policies of drug testing in various countries of this region is expected to fuel the demand & growth of the regional drug testing market during the forecast period.
The right to privacy and prohibition of drug and alcohol testing in various countries are expected to be a leading factor that is slowing down the growth & demand of drug testing in the next few years. In various European nations, like Finland and Belgium, there are strict privacy rights that cannot be neglected while testing for substance abuse. In the Netherlands, pre-employment substance abuse testing is illegal. Several European nations issue penalties for improper testing, with criminal fines. This was a breach of the worker’s privacy. Therefore, these strict privacy rights are expected to hinder the testing process at workplaces, thereby limiting the growth of the market.
The Germany market dominated the Europe Drug Testing Oral Fluid Samples Market by Country 2020, thereby, achieving a market value of $202.4 million by 2027. The UK market is showcasing a CAGR of 3.3% during (2021 - 2027). Additionally, The France market is poised to grow at a CAGR of 4.8% during (2021 - 2027).
Based on Drug Type, the market is segmented into Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others. Based on Sample Type, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Product Type, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on End User, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dragerwerk AG & Co. KGaA, Quidel Corporation, and Omega Laboratories, Inc.
Scope of the Study
Market Segments covered in the Report:
By Drug Type
- Cannabis/Marijuana
- Opioids
- Cocaine
- Alcohol
- Amphetamine & Methamphetamine
- LSD
- Others
By Sample Type
- Urine Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
By Product Type
- Consumables
- Instruments
- Rapid Testing Devices
- Services
By End User
- Drug Testing Laboratories
- Workplaces
- Hospitals
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Quest Diagnostics, Incorporated
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific, Inc.
- Siemens AG (Siemens Healthineers)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Dragerwerk AG & Co. KGaA
- Quidel Corporation
- Omega Laboratories, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe Drug Testing Market by Drug Type
Chapter 4. Europe Drug Testing Market by Sample Type
Chapter 5. Europe Drug Testing Market by Product Type
Chapter 6. Europe Drug Testing Market by End-use
Chapter 7. Europe Drug Testing Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Quest Diagnostics, Incorporated
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific, Inc.
- Siemens AG (Siemens Healthineers)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Dragerwerk AG & Co. KGaA
- Quidel Corporation
- Omega Laboratories, Inc.
Methodology
LOADING...
